These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
103 related articles for article (PubMed ID: 9889730)
1. New diabetes drugs: which one is right for you? Johns Hopkins Med Lett Health After 50; 1999 Jan; 10(11):4-5. PubMed ID: 9889730 [No Abstract] [Full Text] [Related]
2. [Update on new oral treatment for diabetes]. Awad J; Schindel B; Schindel Y Harefuah; 2001 Jan; 140(1):36-9. PubMed ID: 11242897 [No Abstract] [Full Text] [Related]
3. Oral agent therapy in the treatment of type 2 diabetes. Feinglos MN; Bethel MA Diabetes Care; 1999 Apr; 22 Suppl 3():C61-4. PubMed ID: 10189564 [No Abstract] [Full Text] [Related]
4. New therapies for the management of type 2 diabetes. Barnett A Nurs Times; 2001 Feb 8-14; 97(6):34-6. PubMed ID: 11954247 [No Abstract] [Full Text] [Related]
5. 2008 resource guide. Type 2 drugs. There are now six classes of diabetes pills and several combination oral meds. Each has a different way of helping you control your diabetes. McCarren M Diabetes Forecast; 2008 Jan; 61(1):RG7-9. PubMed ID: 18290287 [No Abstract] [Full Text] [Related]
6. Pharmacologic interventions for type 1 and type 2 diabetes. Fain JA; Miller DK Nurs Clin North Am; 2006 Dec; 41(4):589-604, vii. PubMed ID: 17059976 [TBL] [Abstract][Full Text] [Related]
7. New treatment for diabetes. FDA Consum; 2007; 41(1):3. PubMed ID: 17342826 [No Abstract] [Full Text] [Related]
8. Miglitol and hepatotoxicity in type 2 diabetes mellitus. Carlson RF Am Fam Physician; 2000 Jul; 62(2):315, 318. PubMed ID: 10929699 [No Abstract] [Full Text] [Related]
9. Drugs for type 2 diabetes. Treat Guidel Med Lett; 2008 Jul; 6(71):47-54. PubMed ID: 18583949 [No Abstract] [Full Text] [Related]
10. Incretin mimetics and DPP-IV inhibitors for the treatment of type 2 diabetes. Nielsen LL Drug Discov Today; 2005 May; 10(10):703-10. PubMed ID: 15896683 [TBL] [Abstract][Full Text] [Related]
11. Understanding insulin in day-to-day practice. Poole R; Krentz AJ Practitioner; 2001 Apr; 245(1621):324-6, 330, 332 passim. PubMed ID: 11332006 [No Abstract] [Full Text] [Related]
12. Diabetes quiz. How much do you know about Byetta? Flannery L Diabetes Self Manag; 2007; 24(4):52, 54. PubMed ID: 17663084 [No Abstract] [Full Text] [Related]
13. [Sitagliptin. DPP-4 inhibitors as a useful extension of oral diabetes therapy?]. Matthes J; Faust M Dtsch Med Wochenschr; 2008 Oct; 133(43):2233-7. PubMed ID: 18924057 [No Abstract] [Full Text] [Related]
15. Combination therapy in type 2 diabetes: the role of repaglinide. Moses R J Assoc Physicians India; 2001 Jan; 49 Spec No():62-8. PubMed ID: 11235608 [No Abstract] [Full Text] [Related]
16. Pioglitazone and rosiglitazone for diabetes. Drug Ther Bull; 2001 Sep; 39(9):65-8. PubMed ID: 11586802 [TBL] [Abstract][Full Text] [Related]
17. Glitazones in type 2 diabetes: an update. Drug Ther Bull; 2008 Apr; 46(4):25-9. PubMed ID: 18403615 [TBL] [Abstract][Full Text] [Related]
18. Treating type 2 diabetes: targeting the many causative factors. Sutherland JE; Hoehns JD J Fam Pract; 2004 May; 53(5):376-88. PubMed ID: 15125823 [No Abstract] [Full Text] [Related]
19. Combination of drugs in the management of diabetes mellitus. Das S J Indian Med Assoc; 2002 Jul; 100(7):434, 436, 445-7. PubMed ID: 12674168 [TBL] [Abstract][Full Text] [Related]
20. Rationale for dipeptidyl peptidase 4 inhibitors: a new class of oral agents for the treatment of type 2 diabetes mellitus. Campbell RK Ann Pharmacother; 2007 Jan; 41(1):51-60. PubMed ID: 17190843 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]